CLINICAL MONITORING AND PROGNOSTIC ASSESSMENT IN CHRONIC DISEASES
DOI:
https://doi.org/10.55640/Keywords:
chronic disease, clinical monitoring, prognosis, biomarkers, risk stratification, disease surveillance, predictive models, personalized medicine.Abstract
This article presents a comprehensive analysis of clinical monitoring strategies and prognostic assessment methods in chronic diseases. The study examines contemporary approaches to disease surveillance, biomarker-based monitoring, and risk stratification in major chronic conditions including diabetes mellitus, cardiovascular diseases, chronic kidney disease, and chronic respiratory diseases. A prospective cohort study of 580 patients was conducted using standardized monitoring protocols, laboratory biomarkers, imaging techniques, and validated prognostic scoring systems. Results demonstrate that systematic clinical monitoring significantly improves disease outcomes, with early detection of complications reducing hospitalization rates by 34% (p<0.001). Multi-biomarker panels showed superior predictive value compared to single biomarkers (AUC 0.88 vs 0.72, p<0.001). Machine learning-based prognostic models achieved 85% accuracy in predicting 5-year outcomes. The discussion emphasizes the importance of personalized monitoring protocols, integration of digital health technologies, and implementation of evidence-based prognostic tools in clinical practice.
Downloads
References
1. World Health Organization. Noncommunicable diseases country profiles 2018. Geneva: WHO, 2018. 223 p.
2. Wagner E.H., Austin B.T., Davis C., et al. Improving chronic illness care: translating evidence into action // Health Affairs. 2001. Vol. 20(6). P. 64-78. DOI: 10.1377/hlthaff.20.6.64
3. Bodenheimer T., Wagner E.H., Grumbach K. Improving primary care for patients with chronic illness // JAMA. 2002. Vol. 288(14). P. 1775-1779. DOI: 10.1001/jama.288.14.1775
4. Moons K.G.M., Royston P., Vergouwe Y., et al. Prognosis and prognostic research: what, why, and how? // BMJ. 2009. Vol. 338. P. b375. DOI: 10.1136/bmj.b375
5. Obermeyer Z., Emanuel E.J. Predicting the future - big data, machine learning, and clinical medicine // New England Journal of Medicine. 2016. Vol. 375(13). P. 1216-1219. DOI: 10.1056/NEJMp1606181
6. Smith S.M., Wallace E., O'Dowd T., Fortin M. Interventions for improving outcomes in patients with multimorbidity in primary care and community settings // Cochrane Database of Systematic Reviews. 2016. Issue 3. Art. No.: CD006560. DOI: 10.1002/14651858.CD006560.pub3
7. American Diabetes Association. Standards of Medical Care in Diabetes-2023 // Diabetes Care. 2023. Vol. 46(Suppl 1). P. S1-S291. DOI: 10.2337/dc23-Sint
8. Shlipak M.G., Tummalapalli S.L., Boulware L.E., et al. The case for early identification and intervention of chronic kidney disease // Annals of Internal Medicine. 2021. Vol. 174(7). P. 1060-1068. DOI: 10.7326/M20-5813
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.
Germany
United States of America
Italy
United Kingdom
France
Canada
Uzbekistan
Japan
Republic of Korea
Australia
Spain
Switzerland
Sweden
Netherlands
China
India
